AVTR
Avantor, Inc.NYSEHealthcare$7.90+1.67%ClosedMarket Cap: $5.39B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.96
P/S
0.82
EV/EBITDA
64.67
DCF Value
$30.81
FCF Yield
9.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.7%
Operating Margin
-3.8%
Net Margin
-8.1%
ROE
-9.0%
ROA
-14.7%
ROIC
-2.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.66B | 31.5% | $126.4M | $52.4M | $0.08 | — |
| FY 2025 | $6.55B | 32.7% | $-246.2M | $-530.2M | $-0.78 | — |
| Q3 2025 | $1.62B | 32.4% | $-648.8M | $-711.8M | $-1.04 | — |
| Q2 2025 | $1.68B | 32.9% | $128.8M | $64.7M | $0.09 | — |
| Q1 2025 | $1.58B | 33.8% | $147.4M | $64.5M | $0.09 | — |
| Q4 2024 | $1.69B | 33.4% | $638.1M | $500.4M | $0.73 | — |
| FY 2024 | $6.78B | 33.6% | $1.08B | $711.5M | $1.04 | — |
| Q3 2024 | $1.71B | 32.9% | $124.6M | $57.8M | $0.08 | — |
| Q2 2024 | $1.70B | 34.1% | $175.8M | $92.9M | $0.14 | — |
| Q1 2024 | $1.68B | 34.0% | $146.3M | $60.4M | $0.09 | — |
| Q4 2023 | $1.72B | 33.1% | $183.3M | $98.5M | $0.15 | — |
| FY 2023 | $6.97B | 33.9% | $696.4M | $321.1M | $0.47 | — |